APROKAM

This brand name is authorized in Austria, Finland, France, Hong Kong, Netherlands, Poland, Romania, Tunisia, Turkey, United Kingdom

Active ingredients

The drug APROKAM contains one active pharmaceutical ingredient (API):

1 Cefuroxime UNII R8A7M9MY61 - CEFUROXIME SODIUM

Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death. Read about Cefuroxime

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
APROKAM Powder for solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01AA27		S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics
Discover more medicines within S01AA27

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 416325
Country: FR	Base de données publique des médicaments	Identifier(s): 60378168
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 217976
Country: HK	Department of Health Drug Office	Identifier(s): 66973
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 103608
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100288430, 100404898
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W59119001, W59119002, W59119003, W59119004
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 8443141, 8443142H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680177220108, 8680177220115, 8680177220122